Close
Help
Need Help?



Open Access Visibility Statistics for Genomics Insights

Posted Thu, Aug, 16,2012

Articles published in open access journals like Genomics Insights are likely to receive more citations and a higher level of visibility than articles published in restricted access journals.Libertas’ goal is to maximize visibility for all articles published in Genomics Insights and articles in the journal have been viewed more than 36,450 times since 2008. In addition to this, articles have ...

Continue Reading →

Most read paper in Clinical Medicine Insights: Dermatology

Posted Thu, Aug, 16,2012

Clinical Medicine Insights: Dermatology is an open access journal, meaning all articles are available for anyone to download freely without restriction. Open access journals are renowned for having high levels of article visibility compared to traditional subscription journals.One good example of how open access journals can offer high visibility is 'Cosmeceutical Agents: A Comprehensive Revie...

Continue Reading →

Clinical Medicine Insights: Circulatory, Respiratory and Pulmonary Medicine Indexing Partners

Posted Thu, Aug, 16,2012

Libertas works continually to increase online visibility for all our journals, and we are pleased to report that Clinical Medicine Insights: Circulatory, Respiratory and Pulmonary Medicine is now indexed by 18 external online databases and in 10 online directories and search engines.Indexing with so many external databases and directories means that articles published in Clinical Medicine Insights...

Continue Reading →

Evolutionary Bioinformatics Now Uses Project Counter Analytics

Posted Thu, Aug, 16,2012

Enhanced visibility is one of the prime advantages to authors of publishing in an open access journal like Evolutionary Bioinformatics.One of the ways we measure an article's visibility is the number of views and downloads it receives.  The resulting number is available on the journal's webpages for each article, and by adding those numbers together we obtain the journal's visibil...

Continue Reading →

Drug Target Insights Now Uses Project Counter Analytics

Posted Wed, Aug, 15,2012

Enhanced visibility is one of the prime advantages to authors of publishing in an open access journal like Drug Target Insights.One of the ways we measure an article's visibility is the number of views and downloads it receives.  The resulting number is available on the journal's webpages for each article, and by adding those numbers together we obtain the journal's visibility fig...

Continue Reading →

Open Access Visibility Statistics for Glycobiology Insights

Posted Wed, Aug, 15,2012

Articles published in open access journals like Glycobiology Insights are likely to receive more citations and a higher level of visibility than articles published in restricted access journals.Libertas’ goal is to maximize visibility for all articles published in Glycobiology Insights and articles in the journal have been viewed more than 25,851 times since 2008. In addition to this, articl...

Continue Reading →

Our Service Promise

  • Prompt Processing (3 Weeks to Editorial Decision)
  • Fair, Independent Peer Review
  • High Visibility & Extensive Indexing
What Your Colleagues Say About Libertas Academica
I would like to express my gratitude and say that publishing in LA's journals is one of the best experiences I have had.  I will certainly continue with LA's journals in the future.  the unique feature of this publisher is that it provides a research platform for all young researchers.  Thank you for providing a sustainable publishing environment for us.
Dr Syed Wasif Gillani (Lecturer and Researcher, Discipline of Clinical Pharmacy, USM, Malaysia)
More Testimonials

Quick Links




Follow Us We make it easy to find new research papers.




SUBJECT HUBS
Author Survey Results
author_survey_results
All authors are surveyed after their articles are published. Authors are asked to rate their experience in a variety of areas, and their responses help us to monitor our performance. Presented here are their responses in some key areas. No 'poor' or 'very poor' responses were received; these are represented in the 'other' category.
See Our Results